Founder & Chairman
Mr. Zhang has over 30 years of experience in the research and commercialization of immunological products and vaccines. He has led several programs recognized as National Key New Medical Innovation projects in China, including the SARS Immunoglobulin project funded by the Chinese government. Early in his career, Mr. Zhang served as a physician and division head of the Kaifeng area Center for Disease Control and as an epidemiologist with the Zhongmou Center for Disease Control. Mr. Zhang graduated from Kaifeng Health Science School with an associate’s degree in clinical medicine qualifying him as a physician practitioner. Mr. Zhang is also the Director of the Henan Red Cross and the Kaifeng Red Cross.
David (Hui) Shao, Ph.D., MBA
President and CEO, Board of Directors
Dr. Shao has over 20 years of experience in the biopharmaceutical industry with executive roles in finance, management and business strategy. After eight years as Chief Financial Officer and Global Head of Business, Dr. Shao accepted the role of the President & CEO of Yisheng Biopharma in 2018. Prior to joining Yisheng, Dr. Shao was a principal scientist at Roche conducting drug discovery and technology research. He then became a biotech analyst at Mehta Partners and Kamunting Street Capital. Dr. Shao was Chief Financial Officer of Aoxing Pharmaceutical. Dr. Shao received his Ph.D. in Biochemistry from the University of California San Diego, received his bachelor’s degree from the University of Science and Technology of China and holds an MBA from the Stern School of Business of New York University. Dr. Shao is a certified public accountant (CPA) and is a chartered financial analyst (CFA).
Zhongkai Shi, M.D., MBA
Chief Medical Officer
Dr. Shi brings over 20 years of experience in global product development. Prior to joining Yisheng, Dr. Shi led global product development as Director of Clinical Development at the vaccine development organization Aeras. Before Aeras, Dr. Shi was Director of Vaccine Development at Altimmune. He received his M.D. from Beijing University and earned an MBA from the University of Alabama at Birmingham.
Brenda Wu, CPA
Chief Financial Officer
Brenda Wu has over 16 years of financial reporting and financial management experience. Ms. Wu has held management positions at Pharmacy Ltd. and Groud Group, and was previously an auditor at Ernst & Young. Ms. Wu holds a B.A. in accounting and finance from Washington State University and is a certified public accountant (CPA).